Print

TAB9

Safety and Immunogenicity of the Chimeric Protein TAB9 as Vaccine Candidate Against AIDS

Trial Details:

I Completed
Instituto de Medicina Tropical 'Pedro Kouri' December 01, 1996
TAB9 Env B
TAB9 Protein
Cuba 24